Host-microbiota interactions in the infant gut revealed by daily faecal sample time series

Abstract

Aim: This study aims to explore the interplay between host immune factors and gut microbiota in human infants in vivo using time-series daily stool samples and identify biomarkers of host-microbe interactions.

Methods: 216 faecal samples collected from infants aged 5-6 or 11-12 months were analysed for gut microbiota composition, total bacterial load, and biomarkers of immune function.

Results: We identified indications of microbial stimulation of eosinophil cationic protein (ECP), IgA, calprotectin (Cal), intestinal alkaline phosphatase (IAP), and Bactericidal/permeability-increasing protein (BPI) at 6 and 12 months, as well as stimulation of lipocalin 2 (LCN2), lactoferrin (LTF), and alpha-defensin-5 only at 6 months. The associations between biomarker concentrations and bacterial population growth were primarily positive at 6 months and mostly negative at 12 months, suggesting increasing host regulation of the microbiota with age. The exceptions were IAP, which was predictive of declining bacterial populations at both time points, and Cal, whose associations changed from negative at 6 months to positive at 12 months.

Conclusion: There is an age-associated development in the correlation pattern between bacterial population growth and the biomarker concentrations, suggesting that host-microbe interactions change during early development. Albumin appeared as a potential marker of gut permeability, while LCN2 seemed to correlate with gut transit time. Mucin degradation appeared to decrease with age. Mucin2 and IAP emerged as potentially important regulators of the bacterial populations in the infant gut. The study demonstrates the utility of biomarker and bacteria profiling from daily stool samples for analysing in vivo associations between the immune system and the gut microbiota and provides evidence of host regulation of the microbiota in infants.

Keywords

Infant gut microbiome / immune biomarkers / IAP / mucin / lipocalin 2 / albumin

References

[1] de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights.Gut2022;71:1020-32 PMCID:PMC8995832

[2] Bogaert D,de Koff EM.Mother-to-infant microbiota transmission and infant microbiota development across multiple body sites.Cell Host Microbe2023;31:447-60.e6

[3] Homann CM,Dizzell S.Infants’ first solid foods: impact on gut microbiota development in two intercontinental cohorts.Nutrients2021;13:2639 PMCID:PMC8400337

[4] Differding MK,Hoyo C,Mueller NT.Timing of complementary feeding is associated with gut microbiota diversity and composition and short chain fatty acid concentrations over the first year of life.BMC Microbiol2020;20:56 PMCID:PMC7065329

[5] Hou K,Chen XY.Microbiota in health and diseases.Signal Transduct Target Ther2022;7:135 PMCID:PMC9034083

[6] Tanaka M.Development of the gut microbiota in infancy and its impact on health in later life.Allergol Int2017;66:515-22

[7] Yu JC,Malik A.Innate immunity of neonates and infants.Front Immunol2018;9:1759 PMCID:PMC6077196

[8] Liu W,Huo H.Intestinal alkaline phosphatase regulates tight junction protein levels.J Am Coll Surg2016;222:1009-17 PMCID:PMC5684582

[9] Jokela R,Dikareva E.Sources of gut microbiota variation in a large longitudinal Finnish infant cohort.EBioMedicine2023;94:104695 PMCID:PMC10328818

[10] Korpela K, Hurley S, Ford SA, et al; CORAL Study Group. Association between gut microbiota development and allergy in infants born during pandemic-related social distancing restrictions. Allergy 2024;79:1938-51.

[11] Sanna S,van der Graaf A,Zhernakova A.Challenges and future directions for studying effects of host genetics on the gut microbiome.Nat Genet2022;54:100-6

[12] Jian C,Yki-Järvinen H,Korpela K.Quantitative PCR provides a simple and accessible method for quantitative microbiota profiling.PLoS One2020;15:e0227285 PMCID:PMC6961887

[13] Jian C,Korpela K.Commentary: how to count our microbes? The effect of different quantitative microbiome profiling approaches.Front Cell Infect Microbiol2021;11:627910 PMCID:PMC7982878

[14] Pang T,Katz T,Ooi CY.Fecal biomarkers of intestinal health and disease in children.Front Pediatr2014;2:6 PMCID:PMC3904282

[15] Singh SB.Role of intestinal alkaline phosphatase in innate immunity.Biomolecules2021;11:1784 PMCID:PMC8698947

[16] Theprungsirikul J,Rigby WFC.Killing three birds with one BPI: bactericidal, opsonic, and anti-inflammatory functions.J Transl Autoimmun2021;4:100105 PMCID:PMC8187252

[17] Bevins CL.Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis.Nat Rev Microbiol2011;9:356-68

[18] Topic RZ.Eosinophil cationic protein--current concepts and controversies.Biochem Med2011;21:111-21

[19] Damo SM,Sugitani N.Molecular basis for manganese sequestration by calprotectin and roles in the innate immune response to invading bacterial pathogens.Proc Natl Acad Sci U S A2013;110:3841-6 PMCID:PMC3593839

[20] Kell DB,Pretorius E.The biology of lactoferrin, an iron-binding protein that can help defend against viruses and bacteria.Front Immunol2020;11:1221 PMCID:PMC7271924

[21] Takeuchi T.IgA in human health and diseases: potential regulator of commensal microbiota.Front Immunol2022;13:1024330 PMCID:PMC9685418

[22] Johansson MEV,Hansson GC.The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions.Proc Natl Acad Sci U S A2011;108 Suppl 1:4659-65 PMCID:PMC3063600

[23] Wang L,Hartmann P,Chen P.Methods to determine intestinal permeability and bacterial translocation during liver disease.J Immunol Methods2015;421:44-53 PMCID:PMC4451427

[24] Korpela K,Hanski E,de Vos WM.Cohort profile: Finnish Health and Early Life Microbiota (HELMi) longitudinal birth cohort.BMJ Open2019;9:e028500 PMCID:PMC6609051

[25] Salonen A,Jalanka-Tuovinen J.Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: effective recovery of bacterial and archaeal DNA using mechanical cell lysis.J Microbiol Methods2010;81:127-34

[26] Dubois L,Ponsero A.Paternal and induced gut microbiota seeding complement mother-to-infant transmission.Cell Host Microbe2024;32:1011-24.e4

[27] Chen S.Ultrafast one-pass FASTQ data preprocessing, quality control, and deduplication using fastp.Imeta2023;2:e107 PMCID:PMC10989850

[28] Danecek P,Liddle J.Twelve years of SAMtools and BCFtools.Gigascience2021;10:giab008 PMCID:PMC7931819

[29] Hiseni P,Wilson RC,Snipen L.HumGut: a comprehensive human gut prokaryotic genomes collection filtered by metagenome data.Microbiome2021;9:165 PMCID:PMC8325300

[30] Katrikorpela. mare. 2016. Available from: https://zenodo.org/records/50310. [Last accessed on 25 Dec 2024]

[31] Wickham H.Reshaping data with the reshape package.J Stat Soft2007;21:1-20

[32] nlme: linear and nonlinear mixed effects models. Version 3.1-166. 2024.

[33] gplots: various r programming tools for plotting data. Version 3.1.3.1. 2024.

[34] Van den Abbeele P,Thabuis C.Bridging preclinical and clinical gut microbiota research using the ex vivo SIFR® technology.Front Microbiol2023;14:1131662 PMCID:PMC10178071

[35] Hugenholtz F.Mouse models for human intestinal microbiota research: a critical evaluation.Cell Mol Life Sci2018;75:149-60 PMCID:PMC5752736

[36] Nguyen TL,Liston A.How informative is the mouse for human gut microbiota research?.Dis Model Mech2015;8:1-16 PMCID:PMC4283646

[37] Ballard O.Human milk composition: nutrients and bioactive factors.Pediatr Clin North Am2013;60:49-74 PMCID:PMC3586783

[38] Henrick BM,Palumbo MC.Elevated fecal pH indicates a profound change in the breastfed infant gut microbiome due to reduction of Bifidobacterium over the past century.mSphere2018;3:e00041-18 PMCID:PMC5853487

[39] Yamamura R,Nishino K.Intestinal and fecal pH in human health.Front Microbiomes2023;2:1192316

[40] Marchant A.Understanding the ontogeny of the immune system to promote immune-mediated health for life.Front Immunol2015;6:77 PMCID:PMC4337332

[41] Nilsen M,Angell IL.Fecal microbiota nutrient utilization potential suggests mucins as drivers for initial gut colonization of mother-child-shared bacteria.Appl Environ Microbiol2021;87:e02201-20 PMCID:PMC8105027

[42] Ruas-Madiedo P,Fernández-García M,Margolles A.Mucin degradation by Bifidobacterium strains isolated from the human intestinal microbiota.Appl Environ Microbiol2008;74:1936-40 PMCID:PMC2268317

[43] Lemme-Dumit JM,Lwin HW.Altered gut microbiome and fecal immune phenotype in early preterm infants with leaky gut.Front Immunol2022;13:815046 PMCID:PMC8905226

[44] Szymanska E,Dadalski M.Fecal zonulin as a noninvasive biomarker of intestinal permeability in pediatric patients with inflammatory bowel diseases-correlation with disease activity and fecal calprotectin.J Clin Med2021;10:3905 PMCID:PMC8432014

[45] Mantis NJ,Corthésy B.Secretory IgA’s complex roles in immunity and mucosal homeostasis in the gut.Mucosal Immunol2011;4:603-11 PMCID:PMC3774538

[46] Pabst O.IgA and the intestinal microbiota: the importance of being specific.Mucosal Immunol2020;13:12-21 PMCID:PMC6914667

[47] Fawley J.Intestinal alkaline phosphatase: a summary of its role in clinical disease.J Surg Res2016;202:225-34 PMCID:PMC4834149

[48] Martins RDS,Poelstra K.The role of intestinal alkaline phosphatase in the development of necrotizing enterocolitis.Early Hum Dev2023;183:105797

[49] Malo MS.A high level of intestinal alkaline phosphatase is protective against type 2 diabetes mellitus irrespective of obesity.EBioMedicine2015;2:2016-23 PMCID:PMC4703762

[50] Lassenius MI, Fogarty CL, Blaut M, et al; FinnDiane Study Group. Intestinal alkaline phosphatase at the crossroad of intestinal health and disease - a putative role in type 1 diabetes. J Intern Med 2017;281:586-600.

[51] Estaki M,Gibson DL.Interplay between intestinal alkaline phosphatase, diet, gut microbes and immunity.World J Gastroenterol2014;20:15650-6 PMCID:PMC4229529

[52] Malo MS,Muhammad N.Intestinal alkaline phosphatase promotes gut bacterial growth by reducing the concentration of luminal nucleotide triphosphates.Am J Physiol Gastrointest Liver Physiol2014;306:826-38 PMCID:PMC4024727

[53] Garrett WS.249 - Bacteroides, Prevotella, Porphyromonas, and Fusobacterium Species (and other medically important anaerobic gram-negative bacilli). In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. Elsevier; 2015. pp. 2773-80.

[54] Juttukonda LJ.Manganese and nutritional immunity. In: Molecular, genetic, and nutritional aspects of major and trace minerals. Elsevier; 2017. pp. 377-87.

[55] Nisapakultorn K,Herzberg MC.Calprotectin expression inhibits bacterial binding to mucosal epithelial cells.Infect Immun2001;69:3692-6 PMCID:PMC98370

[56] Heinzel S,Kainulainen V.Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individuals.Sci Rep2024;14:13513 PMCID:PMC11169261

[57] Hong L,Han J.Dynamics and crosstalk between gut microbiota, metabolome, and fecal calprotectin in very preterm infants: insights into feeding intolerance.Nutrients2023;15:4849

[58] Lee YM,Choi YJ.Delivery and feeding mode affects fecal calprotectin levels in infants < 7 months old.Early Hum Dev2017;108:45-8

[59] Kolho KL.Concentration of fecal calprotectin in 11,255 children aged 0-18 years.Scand J Gastroenterol2020;55:1024-7

[60] Sommermeyer H,Pszczola M,Piatek J.Supporting the diagnosis of infantile colic by a point of care measurement of fecal calprotectin.Front Pediatr2022;10:978545

[61] Łoniewska B,Węgrzyn D.Analysis of faecal zonulin and calprotectin concentrations in healthy children during the first two years of life. An observational prospective cohort study.J Clin Med2020;9:777 PMCID:PMC7141325

[62] Cekovic JR,Mijailovic SS.The perinatal factors that influence the excretion of fecal calprotectin in premature-born children.Open Med2022;17:1275-81

[63] Zhao C,Ashaolu TJ.Prebiotic and modulatory evidence of lactoferrin on gut health and function.J Funct Foods2023;108:105741

[64] Mastromarino P,Campagna G.Correlation between lactoferrin and beneficial microbiota in breast milk and infant’s feces.Biometals2014;27:1077-86

[65] Sherman MP,Arcinue R.Randomized control trial of human recombinant lactoferrin: a substudy reveals effects on the fecal microbiome of very low birth weight infants.J Pediatr2016;173 Suppl:S37-42

[66] González L,Mosquito S.Oral lactoferrin administration does not impact the diversity or composition of the infant gut microbiota in a Peruvian cohort.Microbiol Spectr2023;11:e0009623 PMCID:PMC10715004

[67] Zilbauer M,Wenzel G.Intestinal alpha-defensin expression in pediatric inflammatory bowel disease.Inflamm Bowel Dis2011;17:2076-86

[68] Savilahti EM,Haahtela T,Kuitunen M.Intestinal defensin secretion in infancy is associated with the emergence of sensitization and atopic dermatitis.Clin Exp Allergy2012;42:405-11

[69] Sugi Y,Kurihara K.α-Defensin 5 gene expression is regulated by gut microbial metabolites.Biosci Biotechnol Biochem2017;81:242-8

[70] Ekkelenkamp MB,Bonten MJM.Chapter 165 - Staphylococci and micrococci. In: Infectious diseases. Elsevier; 2010. pp. 1632-44.

[71] Musher DM. Chapter 30 Haemophilus species. In: Medical microbiology. 1996. Available from: https://www.ncbi.nlm.nih.gov/books/NBK8458/. [Last accessed on 25 Dec 2024]

[72] Shao Y,Tsaliki E.Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth.Nature2019;574:117-21 PMCID:PMC6894937

[73] Asaf S,Jalil J.Lipocalin 2 - not only a biomarker: a study of current literature and systematic findings of ongoing clinical trials.Immunol Res2023;71:287-313 PMCID:PMC9760530

[74] Zollner A,Reider SJ.faecal biomarkers in inflammatory bowel diseases: calprotectin versus lipocalin-2-a comparative study.J Crohns Colitis2021;15:43-54

[75] Jensen BAH,Jonkers D.Small intestine vs. colon ecology and physiology: why it matters in probiotic administration.Cell Rep Med2023;4:101190 PMCID:PMC10518632

[76] Hogan SP.Eosinophil function in eosinophil-associated gastrointestinal disorders.Curr Allergy Asthma Rep2006;6:65-71

[77] Sindi AS,Lai CT.Human milk lactoferrin and lysozyme concentrations vary in response to a dietary intervention.J Nutr Biochem2025;135:109760

[78] Rubio CA.The natural antimicrobial enzyme lysozyme is up-regulated in gastrointestinal inflammatory conditions.Pathogens2014;3:73-92 PMCID:PMC4235737

[79] Zhang C,Zhou K.Intestinal lysozyme1 deficiency alters microbiota composition and impacts host metabolism through the emergence of NAD⁺-secreting ASTB Qing110 bacteria.mSystems2024;9:e0121423 PMCID:PMC10949482

[80] Yang B,Tang B.Characterization of bioactive recombinant human lysozyme expressed in milk of cloned transgenic cattle.PLoS One2011;6:e17593 PMCID:PMC3059212

[81] Huang G,Lu D.Lysozyme improves gut performance and protects against enterotoxigenic Escherichia coli infection in neonatal piglets.Vet Res2018;49:20 PMCID:PMC5819691

[82] Wu Y,Ji L.Dietary lysozyme improves growth performance and intestinal barrier function of weaned piglets.Anim Nutr2023;14:249-58 PMCID:PMC10472418

[83] Humphreys C.Intestinal permeability. Textbook of natural medicine. Elsevier; 2020. pp. 166-77.e4.

[84] Veres-Székely A,Pap D,Bokrossy P.Zonulin as a potential therapeutic target in microbiota-gut-brain axis disorders: encouraging results and emerging questions.Int J Mol Sci2023;24:7548 PMCID:PMC10139156